Rchr
J-GLOBAL ID:201601007508934457   Update date: Apr. 03, 2024

Kawasaki Yuri

Kawasaki Yuri
Research theme for competitive and other funds  (2):
  • 2020 - 2023 SAMD9遺伝子変異が関与する造血異常と易感染性について
  • 2017 - 2020 Research into Blau syndrome using disease-specific iPS cells
Papers (20):
  • 伊佐 真彦[西谷], 向井 康治朗, 本田 吉孝, 仁平 寛士, 田中 孝之, 柴田 洋史, 日衛嶋 栄太郎, 井澤 和司, 川崎 ゆり, 大澤 光次郎, et al. Pyrinインフラマソームの過剰活性化を原因とする新たな自己炎症性疾患 CDC42 C-term病の病態解析. 日本免疫不全・自己炎症学会雑誌. 2022. 1. 2. 70-70
  • Masahiko Nishitani-Isa, Kojiro Mukai, Yoshitaka Honda, Hiroshi Nihira, Takayuki Tanaka, Hirofumi Shibata, Kumi Kodama, Eitaro Hiejima, Kazushi Izawa, Yuri Kawasaki, et al. Trapping of CDC42 C-terminal variants in the Golgi drives pyrin inflammasome hyperactivation. The Journal of experimental medicine. 2022. 219. 6
  • Yohko Kitagawa, Yuri Kawasaki, Yuichi Yamasaki, Naotomo Kambe, Syuji Takei, Megumu K Saito. Anti-TNF treatment corrects IFN-γ-dependent proinflammatory signatures in Blau syndrome patient-derived macrophages. The Journal of allergy and clinical immunology. 2022. 149. 1. 176-188
  • Masahiko Nishitani-Isa, Kojiro Mukai, Yoshitaka Honda, Hiroshi Nihira, Takayuki Tanaka, Hirofumi Shibata, Kumi Kodama, Eitaro Hiejima, Kazushi Izawa, Yuri Kawasaki, et al. Aberrant localization of CDC42 C-terminal variants to the Golgi apparatus drives pyrin inflammasome-dependent autoinflammation. 2021
  • Naoya Kase, Madoka Terashima, Akira Ohta, Akira Niwa, Fumiko Honda-Ozaki, Yuri Kawasaki, Tatsutoshi Nakahata, Nobuo Kanazawa, Megumu K Saito. Pluripotent stem cell-based screening identifies CUDC-907 as an effective compound for restoring the in vitro phenotype of Nakajo-Nishimura syndrome. Stem cells translational medicine. 2021. 10. 3. 455-464
more...
MISC (19):
more...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page